Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

India & Astec LifeSciences

6 shared events · Importance 3 · Last updated Mar 31, 2026

Importance
3
Shared Events
6
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
84
Business
India: India will benefit from increased access to advanced multi-cancer detection screening, potentially improving public health outcomes by enabling earlier diagnosis and treatment of various cancers.
Astec LifeSciences: Astec LifeSciences has partnered with Apollo Hospitals and Guardant Health to introduce the Shield Multi-Cancer Detection test in India, expanding its oncology diagnostics portfolio and market reach. Its shares rose following the announcement.
Jul 03, 2026 · 6 articles
35
Business
India: India is the home country of Cipla and several competing firms, and the deal reflects India's growing role in global biosimilar development.
Astec LifeSciences: Zydus is a competitor developing its own Keytruda biosimilar (FYB206) with Formycon AG, facing similar market opportunities.
Sep 03, 2026 · 6 articles
19
Regulatory
India: Home market of Biocon and several competing biosimilar makers; the approval enhances India's position in global biosimilar exports.
Astec LifeSciences: One of several Indian domestic players marketing a Pertuzumab biosimilar alternative in India, facing increased competition from Biocon's European expansion.
Sep 21, 2026 · 7 articles
0
Business
Astec LifeSciences: Astec LifeSciences is among the Indian pharmaceutical companies that have introduced generic semaglutide brands, contributing to the market shift.
Mar 30, 2026 · 8 articles
0
Business
Mar 20, 2026 · 8 articles
0
Business
Mar 17, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how India and Astec LifeSciences interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.